메뉴 건너뛰기




Volumn 51, Issue 10, 2010, Pages 4867-4874

AGEs and diabetic retinopathy

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED LIPOXIDATION END PRODUCT; AGENTS ACTING ON THE EYE; AMINOGUANIDINE; CARBOHYDRATE DERIVATIVE; CREATININE; HEMOGLOBIN A1C; INSULIN; LACTOYLGLUTATHIONE LYASE; LR 90; METHYLGLYOXAL; PYRIDORIN; PYRIDOXAMINE; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

EID: 77958124842     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5881     Document Type: Review
Times cited : (176)

References (131)
  • 1
    • 33748429057 scopus 로고    scopus 로고
    • Prevention and early detection of vascular complications of diabetes
    • Marshall SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. BMJ. 2006;333:475-480.
    • (2006) BMJ , vol.333 , pp. 475-480
    • Marshall, S.M.1    Flyvbjerg, A.2
  • 2
    • 0026486740 scopus 로고
    • Epidemiology of proliferative diabetic retinopathy
    • Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15:1875-1891.
    • (1992) Diabetes Care , vol.15 , pp. 1875-1891
    • Klein, R.1    Klein, B.E.2    Moss, S.E.3
  • 3
    • 67749088340 scopus 로고    scopus 로고
    • Microvascular lesions of diabetic retinopathy: Clues towards understanding pathogenesis?
    • (Lond.)
    • Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond.). 2009;23:1496-1508.
    • (2009) Eye , vol.23 , pp. 1496-1508
    • Curtis, T.M.1    Gardiner, T.A.2    Stitt, A.W.3
  • 4
    • 0348048874 scopus 로고    scopus 로고
    • Diabetic retinopathy
    • Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
    • (2004) N Engl J Med , vol.350 , pp. 48-58
    • Frank, R.N.1
  • 5
    • 33750597534 scopus 로고    scopus 로고
    • Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease
    • Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes.2006;55:2401-2411.
    • (2006) Diabetes , vol.55 , pp. 2401-2411
    • Antonetti, D.A.1    Barber, A.J.2    Bronson, S.K.3
  • 6
    • 1542636997 scopus 로고    scopus 로고
    • Oscillatory potential analysis and ERGs of normal and diabetic rats
    • Hancock HA, Kraft TW. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Visual Sci. 2004;45: 1002-1008.
    • (2004) Invest Ophthalmol Visual Sci , vol.45 , pp. 1002-1008
    • Hancock, H.A.1    Kraft, T.W.2
  • 7
    • 0038578086 scopus 로고    scopus 로고
    • Visual dysfunction, neurodegenerative diseases, and aging
    • Jackson GR, Owsley C. Visual dysfunction, neurodegenerative diseases, and aging. Neurol Clin. 2003;21:709-728.
    • (2003) Neurol Clin , vol.21 , pp. 709-728
    • Jackson, G.R.1    Owsley, C.2
  • 9
    • 0032529103 scopus 로고    scopus 로고
    • Neural apoptosis in the retina during experimental and human diabetes: Early onset and effect of insulin
    • Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest.1998;102:783-791.
    • (1998) J Clin Invest , vol.102 , pp. 783-791
    • Barber, A.J.1    Lieth, E.2    Khin, S.A.3    Antonetti, D.A.4    Buchanan, A.G.5    Gardner, T.W.6
  • 10
    • 84992616516 scopus 로고
    • The Diabetes Control and Complications Trial Research Group
    • DCCT. Hypoglycemia in the Diabetes Control and Complications Trial
    • DCCT. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes. 1993;46:271286.
    • (1993) Diabetes , vol.46 , pp. 271-286
  • 11
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • (UKPDS) UPDS
    • (UKPDS) UPDS. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
    • (1998) Lancet , vol.352 , pp. 854-865
  • 12
    • 54949157448 scopus 로고    scopus 로고
    • Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives
    • Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 2008;9:315-327.
    • (2008) Rev Endocr Metab Disord , vol.9 , pp. 315-327
    • Madsen-Bouterse, S.A.1    Kowluru, R.A.2
  • 13
    • 0035856980 scopus 로고    scopus 로고
    • Biochemistry and molecular cell biology of diabetic complications
    • Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
    • (2001) Nature , vol.414 , pp. 813-820
    • Brownlee, M.1
  • 14
    • 33947631272 scopus 로고    scopus 로고
    • The potential role of thiamine (vitamin B1) in diabetic complications
    • Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev. 2005;1:287-298.
    • (2005) Curr Diabetes Rev , vol.1 , pp. 287-298
    • Thornalley, P.J.1
  • 15
    • 33646938091 scopus 로고    scopus 로고
    • Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose
    • Berrone E, Beltramo E, Solimine C, Ape AU, Porta M. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem. 2006;281:9307-9313.
    • (2006) J Biol Chem , vol.281 , pp. 9307-9313
    • Berrone, E.1    Beltramo, E.2    Solimine, C.3    Ape, A.U.4    Porta, M.5
  • 16
    • 0344837347 scopus 로고    scopus 로고
    • Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy
    • Hammes HP, Du X, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003;9:294-299.
    • (2003) Nat Med , vol.9 , pp. 294-299
    • Hammes, H.P.1    Du, X.2    Edelstein, D.3
  • 17
    • 23744467295 scopus 로고    scopus 로고
    • Glycation products as markers and predictors of the progression of diabetic complications
    • Monnier VM, Sell DR, Genuth S. Glycation products as markers and predictors of the progression of diabetic complications. Ann N Y Acad Sci. 2005;1043:567-581.
    • (2005) Ann N Y Acad Sci , vol.1043 , pp. 567-581
    • Monnier, V.M.1    Sell, D.R.2    Genuth, S.3
  • 18
    • 33746920337 scopus 로고    scopus 로고
    • Advanced glycation end products: Sparking the development of diabetic vascular injury
    • Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114:597-605.
    • (2006) Circulation , vol.114 , pp. 597-605
    • Goldin, A.1    Beckman, J.A.2    Schmidt, A.M.3    Creager, M.A.4
  • 19
    • 0346731073 scopus 로고    scopus 로고
    • Maillard reaction products in tissue proteins: New products and new perspectives
    • Thorpe SR, Baynes JW. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids.2003;25:275-281.
    • (2003) Amino Acids , vol.25 , pp. 275-281
    • Thorpe, S.R.1    Baynes, J.W.2
  • 20
    • 0028951937 scopus 로고
    • Metabolism of fructose-3- phosphate in the diabetic rat lens
    • Lal S, Szwergold BS, Taylor AH, et al. Metabolism of fructose-3- phosphate in the diabetic rat lens. Arch Biochem Biophys. 1995; 318:191-199.
    • (1995) Arch Biochem Biophys , vol.318 , pp. 191-199
    • Lal, S.1    Szwergold, B.S.2    Taylor, A.H.3
  • 21
    • 0035834748 scopus 로고    scopus 로고
    • Amides are novel protein modifications formed by physiological sugars
    • Glomb MA, Pfahler C. Amides are novel protein modifications formed by physiological sugars. J Biol Chem. 2001;276:41638-41647.
    • (2001) J Biol Chem , vol.276 , pp. 41638-41647
    • Glomb, M.A.1    Pfahler, C.2
  • 22
    • 0033571012 scopus 로고    scopus 로고
    • Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
    • Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 1999;344:109-116.
    • (1999) Biochem J , vol.344 , pp. 109-116
    • Thornalley, P.J.1    Langborg, A.2    Minhas, H.S.3
  • 23
    • 0037302018 scopus 로고    scopus 로고
    • Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
    • Kilhovd BK, Giardino I, Torjesen PA, et al. Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism. 2003;52: 163-167.
    • (2003) Metabolism , vol.52 , pp. 163-167
    • Kilhovd, B.K.1    Giardino, I.2    Torjesen, P.A.3
  • 25
    • 0037406409 scopus 로고    scopus 로고
    • AGEs in foods: Do they play a role in uremia?
    • Henle T. AGEs in foods: do they play a role in uremia? Kidney Int Suppl. 2003;S145-S147.
    • (2003) Kidney Int Suppl
    • Henle, T.1
  • 26
    • 0030992848 scopus 로고    scopus 로고
    • Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy
    • Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A. 1997;94:6474-6479.
    • (1997) Proc Natl Acad Sci U S A , vol.94 , pp. 6474-6479
    • Koschinsky, T.1    He, C.J.2    Mitsuhashi, T.3
  • 27
    • 23744440311 scopus 로고    scopus 로고
    • Diet-derived advanced glycation end products are major contrib-utors to the body's AGE pool and induce inflammation in healthy subjects
    • Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contrib-utors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005;1043:461-466.
    • (2005) Ann N Y Acad Sci , vol.1043 , pp. 461-466
    • Uribarri, J.1    Cai, W.2    Sandu, O.3    Peppa, M.4    Goldberg, T.5    Vlassara, H.6
  • 28
    • 0037180567 scopus 로고    scopus 로고
    • Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy
    • Vlassara H, Cai W, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A. 2002;99:15596-15601.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 15596-15601
    • Vlassara, H.1    Cai, W.2    Crandall, J.3
  • 30
    • 0032032578 scopus 로고    scopus 로고
    • Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia- induced increases in macromolecular endocytosis
    • Shinohara M, Thornalley PJ, Giardino I, et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia- induced increases in macromolecular endocytosis. J Clin Invest. 1998;101:1142-1147.
    • (1998) J Clin Invest , vol.101 , pp. 1142-1147
    • Shinohara, M.1    Thornalley, P.J.2    Giardino, I.3
  • 31
    • 35649026775 scopus 로고    scopus 로고
    • High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A
    • Yao D, Taguchi T, Matsumura T, et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem.2007;282:31038-31045.
    • (2007) J Biol Chem , vol.282 , pp. 31038-31045
    • Yao, D.1    Taguchi, T.2    Matsumura, T.3
  • 32
    • 33744959529 scopus 로고    scopus 로고
    • Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions
    • Miller AG, Smith DG, Bhat M, Nagaraj RH. Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J Biol Chem. 2006;281:11864-11871.
    • (2006) J Biol Chem , vol.281 , pp. 11864-11871
    • Miller, A.G.1    Smith, D.G.2    Bhat, M.3    Nagaraj, R.H.4
  • 33
    • 40549129694 scopus 로고    scopus 로고
    • Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans
    • Morcos M, Du X, Pfisterer F, et al. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging cell. 2008;7:260-269.
    • (2008) Aging Cell , vol.7 , pp. 260-269
    • Morcos, M.1    Du, X.2    Pfisterer, F.3
  • 34
    • 70350365865 scopus 로고    scopus 로고
    • C. elegans as model for the study of high glucose-mediated life span reduction
    • Schlotterer A, Kukudov G, Bozorgmehr F, et al. C. elegans as model for the study of high glucose-mediated life span reduction. Diabetes. 2009;58:2450-2456.
    • (2009) Diabetes , vol.58 , pp. 2450-2456
    • Schlotterer, A.1    Kukudov, G.2    Bozorgmehr, F.3
  • 35
    • 28044450610 scopus 로고    scopus 로고
    • A lethal tetrad in diabetes: Hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction
    • Yu Y, Lyons TJ. A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction. Am J Med Sci. 2005;330:227-232.
    • (2005) Am J Med Sci , vol.330 , pp. 227-232
    • Yu, Y.1    Lyons, T.J.2
  • 36
    • 0034647739 scopus 로고    scopus 로고
    • Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions: Mechanism of action of pyridoxamine
    • Onorato JM, Jenkins AJ, Thorpe SR, Baynes JW. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions: mechanism of action of pyridoxamine. J Biol Chem. 2000;275:21177-21184.
    • (2000) J Biol Chem , vol.275 , pp. 21177-21184
    • Onorato, J.M.1    Jenkins, A.J.2    Thorpe, S.R.3    Baynes, J.W.4
  • 37
    • 0032538529 scopus 로고    scopus 로고
    • Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids
    • Miyata T, Inagi R, Asahi K, et al. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. FEBS Lett. 1998;437:24-28.
    • (1998) FEBS Lett , vol.437 , pp. 24-28
    • Miyata, T.1    Inagi, R.2    Asahi, K.3
  • 38
    • 49249091368 scopus 로고    scopus 로고
    • Evaluation of N (epsilon)-(3- formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy
    • Zhang X, Lai Y, McCance DR, et al. Evaluation of N (epsilon)-(3- formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy. Diabetologia. 2008;51:1723-1730.
    • (2008) Diabetologia , vol.51 , pp. 1723-1730
    • Zhang, X.1    Lai, Y.2    McCance, D.R.3
  • 40
    • 0031752572 scopus 로고    scopus 로고
    • Plasma levels of pentosidine in diabetic patients: An advanced glycation end product
    • Sugiyama S, Miyata T, Ueda Y, et al. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol. 1998;9:1681-1688.
    • (1998) J Am Soc Nephrol , vol.9 , pp. 1681-1688
    • Sugiyama, S.1    Miyata, T.2    Ueda, Y.3
  • 41
    • 7144227270 scopus 로고    scopus 로고
    • Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy
    • Yamaguchi M, Nakamura N, Nakano K, et al. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy. Diabet Med. 1998;15:458-462.
    • (1998) Diabet Med , vol.15 , pp. 458-462
    • Yamaguchi, M.1    Nakamura, N.2    Nakano, K.3
  • 42
    • 30744468605 scopus 로고    scopus 로고
    • Increased serum levels of the specific advanced glycation end product methylglyoxal- derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus
    • Fosmark DS, Torjesen PA, Kilhovd BK, et al. Increased serum levels of the specific advanced glycation end product methylglyoxal- derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. Metabol Clin Exp.2006;55:232-236.
    • (2006) Metabol Clin Exp , vol.55 , pp. 232-236
    • Fosmark, D.S.1    Torjesen, P.A.2    Kilhovd, B.K.3
  • 43
    • 0034741275 scopus 로고    scopus 로고
    • N(epsilon)-(carboxymethyl) lysine levels in patients with type 2 diabetes: Role of renal function
    • Wagner Z, Wittmann I, Mazak I, et al. N(epsilon)-(carboxymethyl) lysine levels in patients with type 2 diabetes: role of renal function. Am J Kidney Dis. 2001;38:785-791.
    • (2001) Am J Kidney Dis , vol.38 , pp. 785-791
    • Wagner, Z.1    Wittmann, I.2    Mazak, I.3
  • 44
    • 0026675759 scopus 로고
    • Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM
    • Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes. 1992;41:1286-1292.
    • (1992) Diabetes , vol.41 , pp. 1286-1292
    • Sell, D.R.1    Lapolla, A.2    Odetti, P.3    Fogarty, J.4    Monnier, V.M.5
  • 45
    • 33644698951 scopus 로고    scopus 로고
    • Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes
    • Genuth S, Sun W, Cleary P, et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes. 2005;54:3103-3111.
    • (2005) Diabetes , vol.54 , pp. 3103-3111
    • Genuth, S.1    Sun, W.2    Cleary, P.3
  • 46
    • 0037093012 scopus 로고    scopus 로고
    • Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
    • Team W. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. Jama. 2002;287:2563-2569.
    • (2002) Jama , vol.287 , pp. 2563-2569
    • Team, W.1
  • 47
    • 0034985014 scopus 로고    scopus 로고
    • Advanced glycation: An important pathological event in diabetic and age related ocular disease
    • Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol. 2001; 85:746-753.
    • (2001) Br J Ophthalmol , vol.85 , pp. 746-753
    • Stitt, A.W.1
  • 48
    • 0031736635 scopus 로고    scopus 로고
    • Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy
    • Stitt AW, Moore JE, Sharkey JA, et al. Advanced glycation end products in vitreous: structural and functional implications for diabetic vitreopathy. Invest Ophthalmol Visual Sci. 1998;39: 2517-2523.
    • (1998) Invest Ophthalmol Visual Sci , vol.39 , pp. 2517-2523
    • Stitt, A.W.1    Moore, J.E.2    Sharkey, J.A.3
  • 49
    • 34548203887 scopus 로고    scopus 로고
    • Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: A case-control study
    • Fosmark DS, Bragadottir R, Stene-Johansen I, et al. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study. Acta Ophthalmol Scand. 2007;85:618-622.
    • (2007) Acta Ophthalmol Scand , vol.85 , pp. 618-622
    • Fosmark, D.S.1    Bragadottir, R.2    Stene-Johansen, I.3
  • 50
    • 0141961133 scopus 로고    scopus 로고
    • Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes
    • Gardiner TA, Anderson HR, Stitt AW. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J Pathol. 2003; 201:328-333.
    • (2003) J Pathol , vol.201 , pp. 328-333
    • Gardiner, T.A.1    Anderson, H.R.2    Stitt, A.W.3
  • 51
    • 0033028542 scopus 로고    scopus 로고
    • Differential accumulation of advanced glycation end products in the course of diabetic retinopathy
    • Hammes HP, Alt A, Niwa T, et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia. 1999;42:728-736.
    • (1999) Diabetologia , vol.42 , pp. 728-736
    • Hammes, H.P.1    Alt, A.2    Niwa, T.3
  • 52
    • 0030805762 scopus 로고    scopus 로고
    • The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas
    • Murata T, Nagai R, Ishibashi T, Inomuta H, Ikeda K, Horiuchi S. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia. 1997;40:764-769.
    • (1997) Diabetologia , vol.40 , pp. 764-769
    • Murata, T.1    Nagai, R.2    Ishibashi, T.3    Inomuta, H.4    Ikeda, K.5    Horiuchi, S.6
  • 53
    • 0033512695 scopus 로고    scopus 로고
    • Amadori albumin in type 1 diabetic patients: Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries
    • Schalkwijk CG, Ligtvoet N, Twaalfhoven H, et al. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes. 1999;48:2446-2453.
    • (1999) Diabetes , vol.48 , pp. 2446-2453
    • Schalkwijk, C.G.1    Ligtvoet, N.2    Twaalfhoven, H.3
  • 54
    • 0031019612 scopus 로고    scopus 로고
    • Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats
    • Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol. 1997;150:523-531.
    • (1997) Am J Pathol , vol.150 , pp. 523-531
    • Stitt, A.W.1    Li, Y.M.2    Gardiner, T.A.3    Bucala, R.4    Archer, D.B.5    Vlassara, H.6
  • 55
    • 0028107538 scopus 로고
    • Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat
    • Hammes HP, Brownlee M, Edelstein D, Saleck M, Martin S, Federlin K. Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia.1994;37:32-35.
    • (1994) Diabetologia , vol.37 , pp. 32-35
    • Hammes, H.P.1    Brownlee, M.2    Edelstein, D.3    Saleck, M.4    Martin, S.5    Federlin, K.6
  • 56
    • 0348049805 scopus 로고    scopus 로고
    • Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats
    • Karachalias N, Babaei-Jadidi R, Ahmed N, Thornalley PJ. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans. 2003;31:1423-1425.
    • (2003) Biochem Soc Trans , vol.31 , pp. 1423-1425
    • Karachalias, N.1    Babaei-Jadidi, R.2    Ahmed, N.3    Thornalley, P.J.4
  • 57
    • 0036723821 scopus 로고    scopus 로고
    • The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes
    • Stitt A, Gardiner TA, Alderson NL, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes. 2002;51:2826-2832.
    • (2002) Diabetes , vol.51 , pp. 2826-2832
    • Stitt, A.1    Gardiner, T.A.2    Alderson, N.L.3
  • 58
    • 0036175576 scopus 로고    scopus 로고
    • Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes
    • Agardh E, Bruun A, Agardh CD. Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes. Curr Eye Res. 2001;23:276-284.
    • (2001) Curr Eye Res , vol.23 , pp. 276-284
    • Agardh, E.1    Bruun, A.2    Agardh, C.D.3
  • 60
    • 0031594369 scopus 로고    scopus 로고
    • Müller cell changes in human diabetic retinopathy
    • Mizutani M, Gerhardinger C, Lorenzi M. Müller cell changes in human diabetic retinopathy. Diabetes. 1998;47:445-449.
    • (1998) Diabetes , vol.47 , pp. 445-449
    • Mizutani, M.1    Gerhardinger, C.2    Lorenzi, M.3
  • 61
    • 0344012015 scopus 로고    scopus 로고
    • Hyperglycemia increases mitochondrial superoxide in retina and retinal cells
    • Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med.2003;35:1491-1499.
    • (2003) Free Radic Biol Med , vol.35 , pp. 1491-1499
    • Du, Y.1    Miller, C.M.2    Kern, T.S.3
  • 62
    • 0142061182 scopus 로고    scopus 로고
    • NADPH diaphorase activity in the rat retina during the early stages of experimental diabetes
    • Li Q, Zemel E, Miller B, Perlman I. NADPH diaphorase activity in the rat retina during the early stages of experimental diabetes. Graefes Arch Clin Exp Ophthalmol. 2003;241:747-756.
    • (2003) Graefes Arch Clin Exp Ophthalmol , vol.241 , pp. 747-756
    • Li, Q.1    Zemel, E.2    Miller, B.3    Perlman, I.4
  • 63
    • 0036981941 scopus 로고    scopus 로고
    • Diabetes-induced dysfunction of retinal Müller cells
    • Puro DG. Diabetes-induced dysfunction of retinal Müller cells. Trans Am Ophthalmol Soc. 2002;100:339-352.
    • (2002) Trans Am Ophthalmol Soc , vol.100 , pp. 339-352
    • Puro, D.G.1
  • 64
    • 0031919598 scopus 로고    scopus 로고
    • Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy
    • Penn State Retina Research Group
    • Lieth E, Barber AJ, Xu B, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes. 1998;47: 815-820.
    • (1998) Diabetes , vol.47 , pp. 815-820
    • Lieth, E.1    Barber, A.J.2    Xu, B.3
  • 65
    • 2442582748 scopus 로고    scopus 로고
    • Cultured retinal neuronal cells and Müller cells both show net production of lactate
    • Winkler BS, Starnes CA, Sauer MW, Firouzgan Z, Chen SC. Cultured retinal neuronal cells and Müller cells both show net production of lactate. Neurochem Int. 2004;45:311-320.
    • (2004) Neurochem Int , vol.45 , pp. 311-320
    • Winkler, B.S.1    Starnes, C.A.2    Sauer, M.W.3    Firouzgan, Z.4    Chen, S.C.5
  • 66
    • 0031762824 scopus 로고    scopus 로고
    • Lipid peroxidation products and antioxidants in human disease
    • Romero FJ, Bosch-Morell F, Romero MJ, et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect. 1998;106(suppl 5):1229-1234.
    • (1998) Environ Health Perspect , vol.106 , Issue.SUPPL. 5 , pp. 1229-1234
    • Romero, F.J.1    Bosch-Morell, F.2    Romero, M.J.3
  • 67
    • 0031737982 scopus 로고    scopus 로고
    • Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress
    • Loske C, Neumann A, Cunningham AM, et al. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm. 1998;105:1005-1015.
    • (1998) J Neural Transm , vol.105 , pp. 1005-1015
    • Loske, C.1    Neumann, A.2    Cunningham, A.M.3
  • 68
    • 0029882361 scopus 로고    scopus 로고
    • Involvement of glycation and oxidative stress in diabetic macroangiopathy
    • Taniguchi N, Kaneto H, Asahi M, et al. Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes. 1996; 45(suppl 3):S81-S83.
    • (1996) Diabetes , vol.45 , Issue.SUPPL. 3
    • Taniguchi, N.1    Kaneto, H.2    Asahi, M.3
  • 69
    • 77649189371 scopus 로고    scopus 로고
    • Molecular pathology of oxidative stress in diabetic angiopathy: Role of mitochondrial and cellular pathways
    • Mokini Z, Marcovecchio ML, Chiarelli F. Molecular pathology of oxidative stress in diabetic angiopathy: role of mitochondrial and cellular pathways. Diabetes Res Clin Pract. 2010;87:313-321.
    • (2010) Diabetes Res Clin Pract , vol.87 , pp. 313-321
    • Mokini, Z.1    Marcovecchio, M.L.2    Chiarelli, F.3
  • 70
    • 63849118178 scopus 로고    scopus 로고
    • Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy
    • Zheng L, Kern TS. Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci. 2009;14:3974-3987.
    • (2009) Front Biosci , vol.14 , pp. 3974-3987
    • Zheng, L.1    Kern, T.S.2
  • 71
    • 28844466951 scopus 로고    scopus 로고
    • Diabetic retinopathy: Mitochondrial dysfunction and retinal capillary cell death
    • Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal. 2005;7: 1581-1587.
    • (2005) Antioxid Redox Signal , vol.7 , pp. 1581-1587
    • Kowluru, R.A.1
  • 72
    • 0142180047 scopus 로고    scopus 로고
    • Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants
    • Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res. 2003;37:1169-1180.
    • (2003) Free Radic Res , vol.37 , pp. 1169-1180
    • Kowluru, R.A.1    Koppolu, P.2    Chakrabarti, S.3    Chen, S.4
  • 74
    • 9444224415 scopus 로고    scopus 로고
    • Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats
    • Kowluru RA, Odenbach S. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes. 2004;53:3233-3238.
    • (2004) Diabetes , vol.53 , pp. 3233-3238
    • Kowluru, R.A.1    Odenbach, S.2
  • 75
    • 33749070956 scopus 로고    scopus 로고
    • Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress
    • Kowluru RA, Kowluru V, Xiong Y, Ho YS. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic Biol Med.2006;41:1191-1196.
    • (2006) Free Radic Biol Med , vol.41 , pp. 1191-1196
    • Kowluru, R.A.1    Kowluru, V.2    Xiong, Y.3    Ho, Y.S.4
  • 76
    • 33847261189 scopus 로고    scopus 로고
    • Arteriolar involvement in the microvascular lesions of diabetic retinopathy: Implications for pathogenesis
    • Gardiner TA, Archer DB, Curtis TM, Stitt AW. Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis. Microcirculation. 2007;14:25-38.
    • (2007) Microcirculation , vol.14 , pp. 25-38
    • Gardiner, T.A.1    Archer, D.B.2    Curtis, T.M.3    Stitt, A.W.4
  • 77
    • 0033071239 scopus 로고    scopus 로고
    • Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas
    • Li W, Yanoff M, Jian B, He Z. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cell Mol Biol (Noisy-le-grand). 1999;45:59-66.
    • (1999) Cell Mol Biol (Noisy-le-grand) , vol.45 , pp. 59-66
    • Li, W.1    Yanoff, M.2    Jian, B.3    He, Z.4
  • 78
    • 33746019252 scopus 로고    scopus 로고
    • Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes
    • Chen BH, Jiang DY, Tang LS. Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes. Life Sci. 2006;79:1040-1048.
    • (2006) Life Sci , vol.79 , pp. 1040-1048
    • Chen, B.H.1    Jiang, D.Y.2    Tang, L.S.3
  • 80
    • 23844515492 scopus 로고    scopus 로고
    • 2+]i signalling and contraction in retinal microvascular pericytes
    • 2+]i signalling and contraction in retinal microvascular pericytes. Mol Vis. 2004;10:996-1004.
    • (2004) Mol Vis , vol.10 , pp. 996-1004
    • Hughes, S.J.1    Wall, N.2    Scholfield, C.N.3
  • 82
    • 1242318593 scopus 로고    scopus 로고
    • Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: Inhibitory effect of gliclazide
    • Mamputu JC, Renier G. Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide. Diabetes Obes Metab.2004;6:95-103.
    • (2004) Diabetes Obes Metab , vol.6 , pp. 95-103
    • Mamputu, J.C.1    Renier, G.2
  • 83
    • 0031019299 scopus 로고    scopus 로고
    • Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: Relevance to diabetic retinopathy
    • Chibber R, Molinatti PA, Rosatto N, Lambourne B, Kohner EM. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia. 1997;40:156-164.
    • (1997) Diabetologia , vol.40 , pp. 156-164
    • Chibber, R.1    Molinatti, P.A.2    Rosatto, N.3    Lambourne, B.4    Kohner, E.M.5
  • 84
    • 14644435056 scopus 로고    scopus 로고
    • Impaired retinal angiogenesis in diabetes: Role of advanced glycation end products and galectin-3
    • Stitt AW, McGoldrick C, Rice-McCaldin A, et al. Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes. 2005;54:785-794.
    • (2005) Diabetes , vol.54 , pp. 785-794
    • Stitt, A.W.1    McGoldrick, C.2    Rice-McCaldin, A.3
  • 85
    • 0036247573 scopus 로고    scopus 로고
    • High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells
    • Padayatti PS, Jiang C, Glomb MA, Uchida K, Nagaraj RH. High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells. Curr Eye Res. 2001;23:106-115.
    • (2001) Curr Eye Res , vol.23 , pp. 106-115
    • Padayatti, P.S.1    Jiang, C.2    Glomb, M.A.3    Uchida, K.4    Nagaraj, R.H.5
  • 86
    • 0141541794 scopus 로고    scopus 로고
    • The role of advanced glycation end products in retinal microvascular leukostasis
    • Moore TC, Moore JE, Kaji Y, et al. The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Visual Sci. 2003;44:4457-4464.
    • (2003) Invest Ophthalmol Visual Sci , vol.44 , pp. 4457-4464
    • Moore, T.C.1    Moore, J.E.2    Kaji, Y.3
  • 87
    • 34247354628 scopus 로고    scopus 로고
    • Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes
    • Canning P, Glenn JV, Hsu DK, Liu FT, Gardiner TA, Stitt AW. Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes. Exp Diabetes Res. 2007;2007:51837.
    • (2007) Exp Diabetes Res , vol.2007 , pp. 51837
    • Canning, P.1    Glenn, J.V.2    Hsu, D.K.3    Liu, F.T.4    Gardiner, T.A.5    Stitt, A.W.6
  • 88
    • 0037263160 scopus 로고    scopus 로고
    • Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: A factor in diabetic retinopathy
    • Xu X, Li Z, Luo D, et al. Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: a factor in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol.2003;241:56-62.
    • (2003) Graefes Arch Clin Exp Ophthalmol , vol.241 , pp. 56-62
    • Xu, X.1    Li, Z.2    Luo, D.3
  • 89
    • 0022644227 scopus 로고
    • Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking
    • Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking. Science. 1986;232:1629-1632.
    • (1986) Science , vol.232 , pp. 1629-1632
    • Brownlee, M.1    Vlassara, H.2    Kooney, A.3    Ulrich, P.4    Cerami, A.5
  • 90
    • 0142121508 scopus 로고    scopus 로고
    • Therapeutic potential of breakers of advanced glycation end product-protein crosslinks
    • Vasan S, Foiles P, Founds H. Therapeutic potential of breakers of advanced glycation end product-protein crosslinks. Arch Biochem Biophys. 2003;419:89-96.
    • (2003) Arch Biochem Biophys , vol.419 , pp. 89-96
    • Vasan, S.1    Foiles, P.2    Founds, H.3
  • 91
    • 0026323337 scopus 로고
    • Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy
    • Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A. 1991;88:11555-11558.
    • (1991) Proc Natl Acad Sci U S A , vol.88 , pp. 11555-11558
    • Hammes, H.P.1    Martin, S.2    Federlin, K.3    Geisen, K.4    Brownlee, M.5
  • 92
    • 0035409354 scopus 로고    scopus 로고
    • Pharmacological inhibition of diabetic retinopathy: Aminoguanidine and aspirin
    • Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes. 2001;50: 1636-1642.
    • (2001) Diabetes , vol.50 , pp. 1636-1642
    • Kern, T.S.1    Engerman, R.L.2
  • 93
    • 0033733494 scopus 로고    scopus 로고
    • Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats
    • Agardh E, Hultberg B, Agardh C. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. Curr Eye Res. 2000;21:543-549.
    • (2000) Curr Eye Res , vol.21 , pp. 543-549
    • Agardh, E.1    Hultberg, B.2    Agardh, C.3
  • 94
    • 10744223527 scopus 로고    scopus 로고
    • Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy
    • Bolton WK, Cattran DC, Williams ME, et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol. 2004;24:32-40.
    • (2004) Am J Nephrol , vol.24 , pp. 32-40
    • Bolton, W.K.1    Cattran, D.C.2    Williams, M.E.3
  • 95
    • 50049083519 scopus 로고    scopus 로고
    • Peroxynitrite-induced protein nitration contributes to liver mitochondrial damage in diabetic rats
    • Ren XY, Li YN, Qi JS, Niu T. Peroxynitrite-induced protein nitration contributes to liver mitochondrial damage in diabetic rats. J Diabetes Complications. 2008;22:357-364.
    • (2008) J Diabetes Complications , vol.22 , pp. 357-364
    • Ren, X.Y.1    Li, Y.N.2    Qi, J.S.3    Niu, T.4
  • 96
    • 0033551042 scopus 로고    scopus 로고
    • Amadorins: Novel post- Amadori inhibitors of advanced glycation reactions
    • Khalifah RG, Baynes JW, Hudson BG. Amadorins: novel post- Amadori inhibitors of advanced glycation reactions. Biochem Biophys Res Commun. 1999;257:251-258.
    • (1999) Biochem Biophys Res Commun , vol.257 , pp. 251-258
    • Khalifah, R.G.1    Baynes, J.W.2    Hudson, B.G.3
  • 97
    • 0036479252 scopus 로고    scopus 로고
    • A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation
    • Voziyan PA, Metz TO, Baynes JW, Hudson BG. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem. 2002;277:3397-3403.
    • (2002) J Biol Chem , vol.277 , pp. 3397-3403
    • Voziyan, P.A.1    Metz, T.O.2    Baynes, J.W.3    Hudson, B.G.4
  • 98
    • 34548299920 scopus 로고    scopus 로고
    • Novel inhibitors of glycation and AGE formation
    • Rahbar S. Novel inhibitors of glycation and AGE formation. Cell Biochem Biophys. 2007;48:147-157.
    • (2007) Cell Biochem Biophys , vol.48 , pp. 147-157
    • Rahbar, S.1
  • 99
    • 41849131467 scopus 로고    scopus 로고
    • A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats
    • Bhatwadekar A, Glenn JV, Figarola JL, et al. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats. Br J Ophthalmol. 2008;92:545-547.
    • (2008) Br J Ophthalmol , vol.92 , pp. 545-547
    • Bhatwadekar, A.1    Glenn, J.V.2    Figarola, J.L.3
  • 100
    • 67650227476 scopus 로고    scopus 로고
    • The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy
    • Gerhardinger C, Dagher Z, Sebastiani P, Seek Park Y, Lorenzi M. The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy. Diabetes.2009;58:1659-1667.
    • (2009) Diabetes , vol.58 , pp. 1659-1667
    • Gerhardinger, C.1    Dagher, Z.2    Sebastiani, P.3    Seek, P.Y.4    Lorenzi, M.5
  • 101
    • 69349088835 scopus 로고    scopus 로고
    • Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response
    • Brucklacher RM, Patel KM, VanGuilder HD, et al. Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics.2008;1:26.
    • (2008) BMC Med Genomics , vol.1 , pp. 26
    • Brucklacher, R.M.1    Patel, K.M.2    van Guilder, H.D.3
  • 102
    • 33847048626 scopus 로고    scopus 로고
    • Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia
    • Vincent JA, Mohr S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes. 2007;56:224-230.
    • (2007) Diabetes , vol.56 , pp. 224-230
    • Vincent, J.A.1    Mohr, S.2
  • 103
    • 70749133081 scopus 로고    scopus 로고
    • Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: Novel mechanism for metabolic memory
    • Chan PS, Kanwar M, Kowluru RA. Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory. J Diabetes Complications. 2010;24:55-63.
    • (2010) J Diabetes Complications , vol.24 , pp. 55-63
    • Chan, P.S.1    Kanwar, M.2    Kowluru, R.A.3
  • 104
    • 7044228789 scopus 로고    scopus 로고
    • A central role for inflammation in the pathogenesis of diabetic retinopathy
    • Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004; 18:1450-1452.
    • (2004) FASEB J , vol.18 , pp. 1450-1452
    • Joussen, A.M.1    Poulaki, V.2    Le, M.L.3
  • 105
    • 3543043820 scopus 로고    scopus 로고
    • Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina
    • Kuiper EJ, Witmer AN, Klaassen I, Oliver N, Goldschmeding R, Schlingemann RO. Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina. Br J Ophthalmol. 2004;88:1082-1087.
    • (2004) Br J Ophthalmol , vol.88 , pp. 1082-1087
    • Kuiper, E.J.1    Witmer, A.N.2    Klaassen, I.3    Oliver, N.4    Goldschmeding, R.5    Schlingemann, R.O.6
  • 106
    • 39049127031 scopus 로고    scopus 로고
    • Microglial activation in human diabetic retinopathy
    • Zeng HY, Green WR, Tso MO. Microglial activation in human diabetic retinopathy. Arch Ophthalmol. 2008;126:227-232.
    • (2008) Arch Ophthalmol , vol.126 , pp. 227-232
    • Zeng, H.Y.1    Green, W.R.2    Tso, M.O.3
  • 108
    • 0033921527 scopus 로고    scopus 로고
    • Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats
    • Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci.2000;17:463-471.
    • (2000) Vis Neurosci , vol.17 , pp. 463-471
    • Zeng, X.X.1    Ng, Y.K.2    Ling, E.A.3
  • 109
    • 0033615356 scopus 로고    scopus 로고
    • N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
    • Kislinger T, Fu C, Huber B, et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem. 1999;274:31740-31749.
    • (1999) J Biol Chem , vol.274 , pp. 31740-31749
    • Kislinger, T.1    Fu, C.2    Huber, B.3
  • 110
    • 2942756123 scopus 로고    scopus 로고
    • Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
    • Liliensiek B, Weigand MA, Bierhaus A, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004;113:1641-1650.
    • (2004) J Clin Invest , vol.113 , pp. 1641-1650
    • Liliensiek, B.1    Weigand, M.A.2    Bierhaus, A.3
  • 111
    • 0033603241 scopus 로고    scopus 로고
    • RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/ calgranulin polypeptides
    • Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/ calgranulin polypeptides. Cell. 1999;97:889-901.
    • (1999) Cell , vol.97 , pp. 889-901
    • Hofmann, M.A.1    Drury, S.2    Fu, C.3
  • 112
    • 0013615899 scopus 로고    scopus 로고
    • RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
    • Yan SD, Chen X, Fu J, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 1996;382:685-691.
    • (1996) Nature , vol.382 , pp. 685-691
    • Yan, S.D.1    Chen, X.2    Fu, J.3
  • 113
    • 0027718105 scopus 로고
    • Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues
    • Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol. 1993;143:1699-1712.
    • (1993) Am J Pathol , vol.143 , pp. 1699-1712
    • Brett, J.1    Schmidt, A.M.2    Yan, S.D.3
  • 114
    • 10744229528 scopus 로고    scopus 로고
    • The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
    • Chavakis T, Bierhaus A, Al-Fakhri N, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med.2003;198:1507-1515.
    • (2003) J Exp Med , vol.198 , pp. 1507-1515
    • Chavakis, T.1    Bierhaus, A.2    Al-Fakhri, N.3
  • 115
    • 0033779614 scopus 로고    scopus 로고
    • RAGE: A new target for the prevention and treatment of the vascular and inflammatory complications of diabetes
    • Schmidt AM, Stern DM. RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol Metab. 2000;11:368-375.
    • (2000) Trends Endocrinol Metab , vol.11 , pp. 368-375
    • Schmidt, A.M.1    Stern, D.M.2
  • 116
    • 27744453362 scopus 로고    scopus 로고
    • Understanding RAGE, the receptor for advanced glycation end products
    • Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med.2005;83:876-886.
    • (2005) J Mol Med , vol.83 , pp. 876-886
    • Bierhaus, A.1    Humpert, P.M.2    Morcos, M.3
  • 117
    • 77954891042 scopus 로고    scopus 로고
    • Homodimerisation is essential for the receptor for advanced glycation end-products (RAGE)-mediated signal transduction
    • Zong H, Madden A, Ward M, Mooney MH, Elliott CT, Stitt AW. Homodimerisation is essential for the receptor for advanced glycation end-products (RAGE)-mediated signal transduction. J Biol Chem. 2010;23:23137-23146.
    • (2010) J Biol Chem , vol.23 , pp. 23137-23146
    • Zong, H.1    Madden, A.2    Ward, M.3    Mooney, M.H.4    Elliott, C.T.5    Stitt, A.W.6
  • 118
    • 57749122052 scopus 로고    scopus 로고
    • Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42
    • Hudson BI, Kalea AZ, Del Mar Arriero M, et al. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem. 2008;283:34457-34468.
    • (2008) J Biol Chem , vol.283 , pp. 34457-34468
    • Hudson, B.I.1    Kalea, A.Z.2    del Mar Arriero, M.3
  • 119
    • 28344438623 scopus 로고    scopus 로고
    • S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells
    • Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res. 2006;312:184-197.
    • (2006) Exp Cell Res , vol.312 , pp. 184-197
    • Hermani, A.1    de Servi, B.2    Medunjanin, S.3    Tessier, P.A.4    Mayer, D.5
  • 120
    • 70149100697 scopus 로고    scopus 로고
    • RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line
    • Chuong C, Katz J, Pauley KM, Bulosan M, Cha S. RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line. J Cell Physiol. 2009;221: 430-434.
    • (2009) J Cell Physiol , vol.221 , pp. 430-434
    • Chuong, C.1    Katz, J.2    Pauley, K.M.3    Bulosan, M.4    Cha, S.5
  • 121
    • 70849096115 scopus 로고    scopus 로고
    • Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
    • Yan SF, Du Yan S, Ramasamy R, Schmidt AM. Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med.2009;25:1-15.
    • (2009) Ann Med , vol.25 , pp. 1-15
    • Yan, S.F.1    du Yan, S.2    Ramasamy, R.3    Schmidt, A.M.4
  • 122
    • 0030811664 scopus 로고    scopus 로고
    • Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury
    • Soulis T, Thallas V, Youssef S, et al. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia. 1997;40:619-628.
    • (1997) Diabetologia , vol.40 , pp. 619-628
    • Soulis, T.1    Thallas, V.2    Youssef, S.3
  • 123
    • 31644450524 scopus 로고    scopus 로고
    • Upregulation of RAGE and its ligands in proliferative retinal disease
    • Pachydaki SI, Tari SR, Lee SE, et al. Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res. 2006;82:807-815.
    • (2006) Exp Eye Res , vol.82 , pp. 807-815
    • Pachydaki, S.I.1    Tari, S.R.2    Lee, S.E.3
  • 124
    • 4644344743 scopus 로고    scopus 로고
    • Receptor for advanced glycation end products and age-related macular degeneration
    • Howes KA, Liu Y, Dunaief JL, et al. Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Visual Sci. 2004;45:3713-3720.
    • (2004) Invest Ophthalmol Visual Sci , vol.45 , pp. 3713-3720
    • Howes, K.A.1    Liu, Y.2    Dunaief, J.L.3
  • 126
    • 77449142258 scopus 로고    scopus 로고
    • Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands
    • Yao D, Brownlee M. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes. 2010;59: 249-255.
    • (2010) Diabetes , vol.59 , pp. 249-255
    • Yao, D.1    Brownlee, M.2
  • 127
    • 78649333713 scopus 로고    scopus 로고
    • Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia responses are regulated by the receptor for advanced glycation end-products (RAGE)
    • In press
    • Zong H, Ward M, Madden A, Yong PH, Limb GA, Stitt AW. Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia responses are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia. 2010. In press.
    • (2010) Diabetologia
    • Zong, H.1    Ward, M.2    Madden, A.3    Yong, P.H.4    Limb, G.A.5    Stitt, A.W.6
  • 128
    • 4644342944 scopus 로고    scopus 로고
    • Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products
    • Marx N, Walcher D, Ivanova N, et al. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products. Diabetes. 2004;53:2662-2668.
    • (2004) Diabetes , vol.53 , pp. 2662-2668
    • Marx, N.1    Walcher, D.2    Ivanova, N.3
  • 129
    • 8444249207 scopus 로고    scopus 로고
    • Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation
    • Yamagishi S, Takeuchi M. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation. Drugs Exp Clin Res. 2004;30:169-175.
    • (2004) Drugs Exp Clin Res , vol.30 , pp. 169-175
    • Yamagishi, S.1    Takeuchi, M.2
  • 130
    • 23644432209 scopus 로고    scopus 로고
    • Angiotensin II augments advanced glycation end product- induced pericyte apoptosis through RAGE overexpression
    • Yamagishi S, Takeuchi M, Matsui T, Nakamura K, Imaizumi T, Inoue H. Angiotensin II augments advanced glycation end product- induced pericyte apoptosis through RAGE overexpression. FEBS Lett. 2005;579:4265-4270.
    • (2005) FEBS Lett , vol.579 , pp. 4265-4270
    • Yamagishi, S.1    Takeuchi, M.2    Matsui, T.3    Nakamura, K.4    Imaizumi, T.5    Inoue, H.6
  • 131
    • 27744574284 scopus 로고    scopus 로고
    • Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension
    • Nakamura K, Yamagishi S, Nakamura Y, et al. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvasc Res. 2005;70:137-141.
    • (2005) Microvasc Res , vol.70 , pp. 137-141
    • Nakamura, K.1    Yamagishi, S.2    Nakamura, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.